Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.77)
# 698
Out of 5,241 analysts
62
Total ratings
57.38%
Success rate
53.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $7.74 | +184.24% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $4.05 | +146.91% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $11.03 | +262.65% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.00 | +900.00% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $10.23 | -41.35% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $3.79 | +243.01% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $38.97 | -48.68% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.10 | +350.98% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $66.93 | +12.06% | 13 | Apr 28, 2025 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $0.52 | +2,812.06% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.72 | +1,353.49% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $49.35 | +1.32% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $7.74
Upside: +184.24%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $4.05
Upside: +146.91%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $11.03
Upside: +262.65%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.00
Upside: +900.00%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $10.23
Upside: -41.35%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $3.79
Upside: +243.01%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $38.97
Upside: -48.68%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.10
Upside: +350.98%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $66.93
Upside: +12.06%
Werewolf Therapeutics
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.52
Upside: +2,812.06%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $1.72
Upside: +1,353.49%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $49.35
Upside: +1.32%